Invida Launches Atopiclair(TM), a Treatment for Atopic Dermatitis Symptoms, at the World Congress of Dermatology 2011
5/26/2011 11:32:19 AM
Invida Group Private Limited today reaffirmed its commitment to patients in Asia Pacific by announcing the launch of a novel atopic dermatitis symptomatic treatment, Atopiclair™, which will be available to patients across Asia in second half of 2011. Atopiclair™, a non-steroidal atopic dermatitis flare-remission treatment, will potentially bring relief to young children and their families, whose lives are significantly impacted by the debilitating effects of the disease. The announcement was made at a press conference today, held in conjunction with the 22nd World Congress of Dermatology 2011 in Seoul, South Korea.